RecruitingNCT05799898

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors

Fast-Track Cardiovascular Assessment for Suspicion of Cardiovascular Events on Immunecheckpoint Inhibitors: Prospective Cohort Study.


Sponsor

Institut Mutualiste Montsouris

Enrollment

200 participants

Start Date

Mar 1, 2022

Study Type

OBSERVATIONAL

Conditions

Summary

Prospective study cohort on patients addressed for suspected cardiovascular event on immune checkpoint inchibitors. Longitudinal prospective single center cohort. Inclusion criteria: all patient willing to particiupate seen in the cardio-oncology unit at our institution for the suspicion of heart failure, atherosclerosis related event, Tako Tsubo, arrhymias, pericarditis, myocarditis on antiPD1, antiPDL1, or antiCTLA4 immune checkpoint inhibitors. Description of patients characteristics, investigations, diagnosis after multidisciplinary meeting, outcomes.


Eligibility

Min Age: 18 Years

Inclusion Criteria1

  • all patient referred to the cardio oncology unit for suspected immune related cardiovascular complication on immune checkpoint inhibitors

Exclusion Criteria1

  • none

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

OTHERNo intervention for research purposes only

No intervention for research purposes only


Locations(1)

Intitut Mutualiste Montsouris

Paris, France

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05799898


Related Trials